Integrated Filing — IndAS
General information about company
| Scrip Code |
508869 |
| NSE Symbol |
APOLLOHOSP |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE437A01024 |
| Name of company |
APOLLO HOSPITALS ENTERPRISE LIMITED |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
10-02-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
16-01-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Third quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Unaudited |
| Segment Reporting |
Multi segment |
| Description of single segment |
|
| Start date and time of board meeting |
10-02-2026 14:45:00 |
| End date and time of board meeting |
10-02-2026 17:40:00 |
| Whether cash flow statement is applicable on company |
|
| Type of cash flow statement |
|
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
31-12-2025 |
31-12-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
6,47,740.00 |
18,62,300.00 |
|
Other income |
5,280.00 |
14,770.00 |
|
Total income |
6,53,020.00 |
18,77,070.00 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
74,460.00 |
2,26,340.00 |
| (b) |
Purchases of stock-in-trade |
2,66,310.00 |
7,44,330.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(2,530.00) |
(3,310.00) |
| (d) |
Employee benefit expense |
74,900.00 |
2,22,830.00 |
| (e) |
Finance costs |
11,260.00 |
33,050.00 |
| (f) |
Depreciation, depletion and amortisation expense
|
21,920.00 |
65,170.00 |
| (f) |
Other Expenses |
| 1 |
Other Expenses |
1,38,070.00 |
3,96,280.00 |
|
Total other expenses |
1,38,070.00 |
3,96,280.00 |
|
Total expenses |
5,84,390.00 |
16,84,690.00 |
| 3 |
Total profit before exceptional items and tax |
68,630.00 |
1,92,380.00 |
| 4 |
Exceptional items |
(1,920.00) |
(1,920.00) |
| 5 |
Total profit before tax |
66,710.00 |
1,90,460.00 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
14,700.00 |
43,330.00 |
| 8 |
Deferred tax |
1,870.00 |
5,480.00 |
| 9 |
Total tax expenses |
16,570.00 |
48,810.00 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
50,140.00 |
1,41,650.00 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
1,490.00 |
3,480.00 |
| 16 |
Total profit (loss) for period |
51,630.00 |
1,45,130.00 |
| 17 |
Other comprehensive income net of taxes |
(20.00) |
6,250.00 |
| 18 |
Total Comprehensive Income for the period |
51,610.00 |
1,51,380.00 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
50,230.00 |
1,41,230.00 |
|
Total profit or loss, attributable to non-controlling interests |
1,400.00 |
3,900.00 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
50,220.00 |
1,47,470.00 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
1,390.00 |
3,910.00 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
7,190.00 |
7,190.00 |
|
Face value of equity share capital |
5 |
5 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
34.94 |
98.23 |
|
Diluted earnings (loss) per share from continuing operations |
34.94 |
98.23 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
34.94 |
98.23 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
34.94 |
98.23 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| Date of end of reporting
period |
31-12-2025 |
31-12-2025 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
a) Healthcare services |
3,22,530.00 |
9,41,640.00 |
| 2 |
b) Retail health and diagnostics |
46,680.00 |
1,37,580.00 |
| 3 |
c) Digital health and pharmacy distribution |
2,82,750.00 |
7,95,990.00 |
| 4 |
d) Others |
0.0013 |
0.0039 |
|
Total Segment Revenue |
6,52,090.00 |
18,75,600.00 |
|
Less: Inter segment revenue |
4,350.00 |
13,300.00 |
|
Revenue from operations |
6,47,740.00 |
18,62,300.00 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
a) Healthcare services |
62,430.00 |
1,81,580.00 |
| 2 |
b) Retail health and diagnostics |
1,170.00 |
3,240.00 |
| 3 |
c) Digital health and pharmacy distribution |
10,800.00 |
26,310.00 |
| 4 |
d) Others |
210.00 |
(470.00) |
|
Total Profit before tax |
74,610.00 |
2,10,660.00 |
|
i. Finance cost |
11,260.00 |
33,050.00 |
|
ii. Other Unallocable Expenditure net off Unallocable income |
5,280.00 |
14,770.00 |
|
Profit before tax |
58,070.00 |
1,62,840.00 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
a) Healthcare services |
13,66,510.00 |
13,66,510.00 |
| 2 |
b) Retail health and diagnostics |
1,39,920.00 |
1,39,920.00 |
| 3 |
c) Digital health and pharmacy distribution |
3,19,370.00 |
3,19,370.00 |
| 4 |
d) Others |
2,640.00 |
2,640.00 |
|
Total Segment Asset |
18,28,440.00 |
18,28,440.00 |
|
Un-allocable Assets |
4,16,210.00 |
4,16,210.00 |
|
Net Segment Asset |
22,44,650.00 |
22,44,650.00 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
a) Healthcare services |
4,35,590.00 |
4,35,590.00 |
| 2 |
b) Retail health and diagnostics |
1,16,360.00 |
1,16,360.00 |
| 3 |
c) Digital health and pharmacy distribution |
94,250.00 |
94,250.00 |
| 4 |
d) Others |
1,820.00 |
1,820.00 |
|
Total Segment Liabilities |
6,48,020.00 |
6,48,020.00 |
|
Un-allocable Liabilities |
5,86,550.00 |
5,86,550.00 |
|
Net Segment Liabilities |
12,34,570.00 |
12,34,570.00 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
31-12-2025 |
31-12-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
'Remeasurement gains / (losses) on defined benefit plan |
(90.00) |
(400.00) |
| 2 |
'Equity instruments through other comprehensive income |
0.00 |
7,450.00 |
|
Total Amount of items that will not be reclassified to profit and loss |
(90.00) |
7,050.00 |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
(30.00) |
950.00 |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
| 1 |
Exchange differences in translating the financial statements of foreign operations |
40.00 |
150.00 |
|
Total Amount of items that will be reclassified to profit and loss |
40.00 |
150.00 |
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
0.00 |
0.00 |
| 5 |
Total Other comprehensive income |
(20.00) |
6,250.00 |
Details of Impact of Audit Qualification
Amount in (Lakhs)
| Whether results are audited or unaudited |
Unaudited |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
| Auditor's opinion |
|
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015:
The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified
opinion for the period on Standalone results |
Yes |
| Sr No. |
Audit firm's name |
Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI |
Certificate valid upto |
| 1 |
DELOITTE HASKINS & SELLS LLP |
Yes |
31-07-2027 |